Andrew Althouse Profile Banner
Andrew Althouse Profile
Andrew Althouse

@ADAlthousePhD

Followers
12,039
Following
2,991
Media
1,532
Statuses
28,929

Statistician @Medtronic , studying novel statistical methods to do more efficient clinical trials; enjoy kettlebells, deadlifts, whiskey, craft beer & food

Joined July 2017
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@ADAlthousePhD
Andrew Althouse
3 years
I will gradually populate this with R code to run simulations of various RCT scenarios. Posting link here so I can pin this tweet.
4
31
151
@ADAlthousePhD
Andrew Althouse
4 years
God grant me the confidence of the reviewer who doesn’t know regression models can include both continuous and categorical variables.
35
99
2K
@ADAlthousePhD
Andrew Althouse
6 years
The most successful people I’ve met: 1) are jerks. 2) have sacrificed family for success 3) do whatever benefits them The people I want to be like: 1) are nice 2) have sacrificed a small part of career for family 3) do the right thing, not the thing that benefits them the most
@APompliano
Pomp 🌪
6 years
The most successful people I've met: 1. Read constantly 2. Workout daily 3. Are innately curious 4. Have laser focus 5. Believe in themselves 6. Build incredible teams 7. Admit they know very little 8. Constantly work to improve 9. Demand excellence in everything they do
1K
10K
36K
31
274
1K
@ADAlthousePhD
Andrew Althouse
6 years
Statistician's tip of the day: if someone tells you that they "just have a few Excel sheets" that they want help with, run the other way. Also, you may want to give them a fake phone number, possibly a fake name. It may be worth faking your own death, in extreme circumstances.
23
208
932
@ADAlthousePhD
Andrew Althouse
5 years
Update: our effort to compile crowdsourced list of references on some "Common Statistical Myths" is now a wiki on DataMethods - please feel free to go there and add your own topics and/or references!
19
362
790
@ADAlthousePhD
Andrew Althouse
4 years
Ok: best statistics-themed band names. I’ll go first. Proportional Hazards (Now that I think about this, a *ton* of statistics terms work as band names...hey did you get the new Proportional Hazards album?)
463
94
656
@ADAlthousePhD
Andrew Althouse
4 years
The NEJM compassionate-use remdesivir data was always sort of a "passing curiosity while we await trial data" but it's disappointing that the analysis was done wrong. But, it offers an opportunity for a teachable moment about "time-to-event" analysis of non-mortality outcomes.
30
230
634
@ADAlthousePhD
Andrew Althouse
5 years
Hello, 9-1-1 emergency? I’d like to report a crime against data visualization.
Tweet media one
24
110
593
@ADAlthousePhD
Andrew Althouse
5 years
Occasionally, I see papers with >20 authors (all MD) & an "acknowledgement" for the person that did the statistical analyses. Why? Would've been too much trouble for *one more* author's name to appear on the byline? It's not like you're adhering to an author limit anyway...
21
61
612
@ADAlthousePhD
Andrew Althouse
6 years
After 10 years of doing >90 percent of my analysis in SAS, today I decided to muck around some with R (which I’ve only dipped into sporadically since undergrad). WHY DIDN’T ANYONE TELL ME HOW MUCH COOL STUFF HAS BEEN ADDED TO R IN THOSE 10 YEARS?!
18
61
536
@ADAlthousePhD
Andrew Althouse
2 years
I've said/done this before, but again: the BMJ Statistics Notes series from the mid-late 1990's really give some nice, neat little examples to help explain tricky concepts with statistics in medicine, and I try to read through one or two every week...
11
89
503
@ADAlthousePhD
Andrew Althouse
5 years
Hi! I’m a biostatistician. You might know me from my greatest hits including “No, we can’t really calculate 10 year survival for something that’s only been used for seven years” and “No, you shouldn’t say that p=0.08 is ‘trending towards’ significance”
@mad_sters
Madeline Sterling, MD, MPH, FAHA
5 years
Hi! I'm a general internist. You might know me from my greatest hits including "So, tell me how you are? you heard me, I really care about everything!" or "Yup, I can (try to) coordinate all of that!" or "Not only will I figure out what you have, but I'll fill out your forms"
0
14
91
13
61
459
@ADAlthousePhD
Andrew Althouse
5 years
Hello, I’m a statistician in a movie. Just kidding. Statisticians are NEVER in movies.
@_roryturnbull
Rory Turnbull
5 years
Hello, I'm a professor in a movie, I only reach the main point of my lecture right as class is ending. Then I yell at students about the reading / homework as they leave.
5K
21K
155K
19
25
423
@ADAlthousePhD
Andrew Althouse
7 months
I too stand with JAMA in saying that nuclear war is bad and we shouldn’t do one
@JAMAPediatrics
JAMA Pediatrics
7 months
JAMA and JAMA Network journals join journals worldwide to call on health professionals to warn the public about major danger to health and essential life support systems posed by the threat of nuclear war and urge action to prevent use of nuclear weapons.
22
8
40
47
44
427
@ADAlthousePhD
Andrew Althouse
5 years
Here's your daily reminder that "do univariable analysis & stick all variables with p<0.05 into a multivariable model" is not an optimal model-building strategy for pretty much anything.
17
80
384
@ADAlthousePhD
Andrew Althouse
5 years
I wonder if anyone that lost their mind about this on Twitter over the last two days has bothered to read this, or to consider any of the following things:
26
127
364
@ADAlthousePhD
Andrew Althouse
5 years
Today, I received a resubmission of a paper that I had previously reviewed that used stepwise regression. In my comments, I advised that they use a DAG, as it seemed appropriate for their problem... AND THEY ACTUALLY DID IT! Just about fell out of my chair.
13
21
361
@ADAlthousePhD
Andrew Althouse
4 years
Hey stats twitter, what’s the preferred method for handling “missing outcome data due to global pandemic that canceled outcome assessments for a few months?” Asking for a friend. Ok, for me.
17
37
350
@ADAlthousePhD
Andrew Althouse
3 years
Small academic wins: Today, we received comments back on a grant with the following note in the first paragraph: "It is clear from the write up of the sample size estimation and analysis plan that there is a good statistician involved in the project."
11
9
347
@ADAlthousePhD
Andrew Althouse
4 years
As promised last week, here is a thread to explore and explain some beliefs about interim analyses and efficacy stopping in randomized controlled trials.
19
116
326
@ADAlthousePhD
Andrew Althouse
2 years
Personal news: after 4+ wonderful years in @PittGIM and 14+ years affiliated with the University of Pittsburgh as a graduate student and collaborative statistician, I've joined @Medtronic in the Structural Heart & Aortic unit.
62
5
318
@ADAlthousePhD
Andrew Althouse
6 years
My ten-day N-of-1 trial strongly suggests that fatherhood has a benefit on quality of life. Possible confounding variable: not going to work during those ten days.
16
13
296
@ADAlthousePhD
Andrew Althouse
5 years
Yesterday I got blocked by a sportswriter for explaining that the ability to call a coin toss is not an advantage, and that both teams have 50% chance to win the toss regardless of what is called.
@trpender
Tricia Pendergrast, MD
5 years
I wish twitter told you when you were blocked so you could do an exit interview
1
2
74
24
32
288
@ADAlthousePhD
Andrew Althouse
5 years
“Ugh, this paper has another logistic regression with way too many variables for such a small dataset. You’d think by now people would know, but NO! This is the 12th time this year I’ve written the same reviewer comment, and it’s only March!” “Sir, this is an Arby’s.”
10
23
277
@ADAlthousePhD
Andrew Althouse
6 years
This article calls for a TWEETORIAL (h/t to the clever @boback and @ihtanboga for catching this and posting about it)
@NEJM
NEJM
6 years
Trial finds no significant difference in 60-day mortality between early ECMO and conventional treatment with ECMO backup in patients with severe ARDS. Full trial results:
Tweet media one
5
129
124
31
205
280
@ADAlthousePhD
Andrew Althouse
5 years
Intro: why did you do this? Methods: what did you do? Results: what did you find? Discussion: what did we learn, and how does this fit with what else we currently think / know / do?
6
64
279
@ADAlthousePhD
Andrew Althouse
2 years
Every statistician / analyst, here’s the rationalization you’ve been searching for to explain why after 10+ years of working with your took of choice (SAS, Stata, R, whatever) you still google “reshape data long to wide”
9
28
275
@ADAlthousePhD
Andrew Althouse
5 years
I dislike how the association of the word "significant" with "is the p-value<0.05?" makes me afraid to ever use the word "significant" in any phrase describing data.
11
14
221
@ADAlthousePhD
Andrew Althouse
5 years
When I arrive in town for a conference at a city I’ve never been to, I like to go to the hotel bar alone and imagine that I’m actually some sort of CIA action hero coolly scoping the joint and waiting for my contact to reveal themselves.
7
3
235
@ADAlthousePhD
Andrew Althouse
2 years
Noninferiority trials: a musing thread that I may regret. NI trials are fickle & unsatisfying. Sometimes there's a legitimately good reason to do them (discussed below); the stats are maddening (also discussed below).
7
61
236
@ADAlthousePhD
Andrew Althouse
3 years
Here is a little intro thread on how to do simulations of randomized controlled trials. This thread will take awhile to get all the way through & posted, so please be patient. Maybe wait a few minutes and then come back to it.
4
44
233
@ADAlthousePhD
Andrew Althouse
4 years
Hey everyone, I'm not *trying* to brag here, but I just wrote an R function that actually does the thing that I wanted it to, and it only took me two help pages and an hour of trial and error. PROGRESS.
5
5
221
@ADAlthousePhD
Andrew Althouse
4 years
To whom it may concern: a power calculation that is used to justify a trial's sample size should be performed using the same statistical approach that will be used to analyze the data.
8
18
219
@ADAlthousePhD
Andrew Althouse
3 years
You don’t need p-values in Table 1 of that randomized trial.
@halleberry
Halle Berry
3 years
tell me something I don’t know.
Tweet media one
3K
728
16K
8
7
216
@ADAlthousePhD
Andrew Althouse
5 years
“By "learned R", I mean I copied pieces of code from around the internet” - that’s how we all do it...
@AnneLikesSleep
Dr Anne Koopman | AnneLikesSleep.bsky.social
5 years
Someone told me the graphs in my draft chapter were ugly. So I learned R* and made all the graphs with ggplot just to spite this person, and if that doesn't summarize me... *By "learned R", I mean I copied pieces of code from around the internet. #rstats #phdlife
27
38
979
8
19
204
@ADAlthousePhD
Andrew Althouse
4 years
A look ahead: The year is 2050... COVID19 is still endemic. HCQ has repeatedly failed to improve outcomes for COVID19 prevention & treatment in RCT’s. A nonrandomized single center study shows better outcomes in patients that got HCQ. Media headline: NEW STUDY SHOWS...
7
34
200
@ADAlthousePhD
Andrew Althouse
4 years
Hear me out: an app for toddler parents that shows the location of all construction vehicles and other heavy machinery in your area. Does this exist? If not, can someone make this happen?
10
3
204
@ADAlthousePhD
Andrew Althouse
4 years
Just sent an email to myself as a reminder to do something and ended it with “Thanks, Andrew” so that’s where things stand today.
12
4
200
@ADAlthousePhD
Andrew Althouse
6 years
I've been a mere spectator to the Wansink scandal, but I think the cautionary tale is worth amplifying across the fields of statistics, medicine & the entire research community. Thus far, the discussion *seems* mostly confined to psychology researchers & some statisticians.
@RetractionWatch
Retraction Watch
6 years
Update: @BrianWansink "committed academic misconduct," Cornell finds. He resigned today.
1
30
31
8
108
201
@ADAlthousePhD
Andrew Althouse
1 year
Reminder: a treatment effect is shown in an RCT by showing a difference between the treatment group and control group, not by showing a significant change from baseline in one group only.
Tweet media one
10
41
216
@ADAlthousePhD
Andrew Althouse
5 years
From a friend: “My main concern is whether the journal wants to publish a study that does not include a significant result as the main outcome.” This is not a thing that should be written by reviewers in 2019.
12
34
205
@ADAlthousePhD
Andrew Althouse
5 years
“You know what, that logistic regression with 18 predictor variables and 22 clinical events is just fine”
3
15
200
@ADAlthousePhD
Andrew Althouse
4 years
OK. The culmination of a year-plus, um, argument-like thing is finally here, and it's clearly going to get discussed on Twitter, so I'll post a thread on the affair for posterity & future links about my stance on this entire thing.
12
48
200
@ADAlthousePhD
Andrew Althouse
6 years
TOPIC: P-Values In Table 1 of RCT's. Time to revisit this poll.
@ADAlthousePhD
Andrew Althouse
6 years
CLINICAL COLLEAGUES ONLY ( #statstwitter , please sit this one out): if you were reading the primary outcomes paper from a randomized controlled trial, do you expect to see p-values comparing baseline characteristics of the treatment arms in Table 1?
9
19
38
9
75
202
@ADAlthousePhD
Andrew Althouse
5 years
Why you shouldn't dichotomize continuous outcome variables, a brief thread:
15
61
186
@ADAlthousePhD
Andrew Althouse
5 years
If you have <100 patients and <20 incidents of your primary outcome, please, don’t create a multivariable logistic regression and say that you have identified “independent risk factors” for that outcome in that population.
5
32
178
@ADAlthousePhD
Andrew Althouse
5 years
Hi @scottlemaire , I would like to issue a public expression of concern about a paper published recently in the Journal of Surgical Research, on which you are the editor in chief.
9
30
168
@ADAlthousePhD
Andrew Althouse
5 years
Yeah, it’s a no from me. Making authors reformat a paper every time they want to submit to a new journal just to learn if the EIC will send for a review is not a win for anyone except the journal feeling like authors “respect the process”
@DrMuzz57
Murray Thomson
5 years
@ADAlthousePhD @EndChildCrisis @ZackBergerMDPhD If you wish your work to be considered seriously by a journal, do it the honour of meeting its requirements. As an editor, I have to make decisions on >620 papers a year. I’m not going to waste my time on authors who don’t respect the process
14
1
16
7
26
166
@ADAlthousePhD
Andrew Althouse
2 years
The great and terrible thing about being on Twitter (for a stats/methods person) is that it shows you just how much is out there to learn.
3
23
181
@ADAlthousePhD
Andrew Althouse
2 years
Amazing that “responders” survive longer than “non-responders” when part of being defined as a responder is *surviving long enough* to be classified as a responder
@gonen_mithat
Mithat Gönen
2 years
#ImmortalTimeBias is alive and well at @JCO_ASCO in 2022, 39 years after the same journal published the seminal article that taught us not to do what is done in this article @Merregan @tmprowell
Tweet media one
7
30
150
8
17
172
@ADAlthousePhD
Andrew Althouse
6 years
More problems with logistic regression in the medical literature:
9
60
166
@ADAlthousePhD
Andrew Althouse
3 years
Reviewer Comment just received on primary RCT report: "Table 1 should include significance values for the values reported between (treatment name redacted) and placebo groups"
21
16
164
@ADAlthousePhD
Andrew Althouse
4 years
Seems that I picked up some new followers overnight. I’m just about out of useful ideas after 3 years on Twitter but next week I do plan to put together a thread on interim analyses in clinical trials and some myths-vs-truths for interpreting trials that were stopped early.
6
7
170
@ADAlthousePhD
Andrew Althouse
5 years
@DrMuzz57 @EndChildCrisis @ZackBergerMDPhD I’m an editor, too, and see no reason that all formatting req’s need be met for the EIC to take a first look and decide whether the paper merits being sent for review or not. How many thousand of man-hours that could be spent more productively are wasted on this?
4
6
167
@ADAlthousePhD
Andrew Althouse
5 years
The *most amazing* thing happened today: a statistical reviewer told us to take the p-values OUT of table 1! I will be showing this to all current and future collaborators that insist on putting them in.
13
21
161
@ADAlthousePhD
Andrew Althouse
5 years
Andrew: “hey Editor, this paper used an unpaired t-test on what’s clearly paired data, suggest looking into this.” Editor: “Thank you for your comment. This paper passed a rigorous peer review process. You are welcome to submit your concerns as a Letter.”
16
28
154
@ADAlthousePhD
Andrew Althouse
5 years
Hilariously, minutes after I posted this thread, one of my own collaborative papers was rejected with the following comment: "It seems that the authors do not have formal statistical degree training. With the help of a statistician..." Ouchtown, population me.
@ADAlthousePhD
Andrew Althouse
5 years
@MaartenvSmeden @DRTomlinsonEP @drjohnm @jamesheathers Anyways, that's quite a ramble, but those are (most of) my thoughts on the utility of and realistic expectations for statistical review in medical journals.
0
0
10
11
6
151
@ADAlthousePhD
Andrew Althouse
5 years
MEMO: really, it's okay to NOT do "multivariable analysis" if your dataset is too small. I would rather read a dozen descriptive studies than another 1 attempting to cram "multivariable" logistic regression to identify "independent predictors" of something with <100 patients.
5
42
156
@ADAlthousePhD
Andrew Althouse
4 years
As more stuff continues to break on the @NEJM and @TheLancet papers using the Surgisphere 'data' there's another possibility which has occurred to me that I want to play out.
25
54
156
@ADAlthousePhD
Andrew Althouse
2 years
Inspired by this & some other recent discussions of the win ratio approach, here comes a little tutorial on the "win ratio" approach to analysis of RCT data.
@DrRoseDasgupta
Rose (Pritika) Dasgupta, PhD MPH MHI MS
2 years
At work (I work on clinical trials), I just learned how to perform a win ratio analysis using #rstats (using the BuyseTest package)!! Thanks for showing me how @ADAlthousePhD
0
1
15
14
30
168
@ADAlthousePhD
Andrew Althouse
4 years
Tweet media one
1
15
154
@ADAlthousePhD
Andrew Althouse
5 years
If you expect me to enroll in a randomized trial where I could be assigned to a “no bacon” arm, THINK AGAIN, ROBERT.
10
24
148
@ADAlthousePhD
Andrew Althouse
5 years
I just want to highlight that for anyone interested in statistical analyses in the practice of epidemiology or medicine, there is an exchange between two field giants going on here that is very thought-provoking:
7
53
141
@ADAlthousePhD
Andrew Althouse
4 years
And not a single full push-up was done that day.
@DrOz
Dr. Mehmet Oz
4 years
It really happened! The push-up challenge to end our breakfast feud! 💪🏻💪🏻 Tune in Wednesday to see my full workout with @markwahlberg at @f45training . We also discuss intermittent fasting and the food hack that helped Mark lose weight. Set your DVR now!
140
72
843
14
6
147
@ADAlthousePhD
Andrew Althouse
5 years
@joonghee_emdoc Incredible class and grace. Your intentions were good and IMO you have nothing to apologize for.
2
1
145
@ADAlthousePhD
Andrew Althouse
5 years
This poor student, in Korea, a country about which I know precious little but others have said is not a bastion of gender equality, wrote a paper trying to provide data to help *combat* gender stereotypes, and medtwitter came out in full force to beat her skull in for it.
1
28
134
@ADAlthousePhD
Andrew Althouse
5 years
“The p-value is the probability that the null hypothesis is true”
4
11
138
@ADAlthousePhD
Andrew Althouse
6 years
(THREAD) A few months ago, the Annals of Medicine published a controversial piece titled “Why all randomized controlled trials produce biased results.” Topic: not a bad idea - we should examine trials carefully. Execution: left something to be desired.
4
77
141
@ADAlthousePhD
Andrew Althouse
4 years
Thread (for prospective PI's and lead authors) on collaborating with a statistician in clinical research:
7
51
140
@ADAlthousePhD
Andrew Althouse
5 years
Today I fulfilled a lifelong dream: I was actually the “random man at community event interviewed by the local news” (in this case, dropping off glass bottles for recycling...)
Tweet media one
10
0
142
@ADAlthousePhD
Andrew Althouse
4 years
Look I can’t speak for all epidemiologists but I had a tremendous GRE score
12
7
130
@ADAlthousePhD
Andrew Althouse
5 years
12
5
133
@ADAlthousePhD
Andrew Althouse
2 years
one of my favorite things about working with extremely smart and senior academics is seeing how many of them still hit Enter 15 times to get onto a new page of a Word document instead of inserting page breaks
11
2
143
@ADAlthousePhD
Andrew Althouse
4 years
They used OLS with a binary outcome.
3
8
133
@ADAlthousePhD
Andrew Althouse
5 years
(THREAD) misleading results from subgroup analysis combined with regression to the mean in crossover RCT’s. Pull up a chair, let’s have a chat.
7
44
132
@ADAlthousePhD
Andrew Althouse
5 years
The frustrating thing about the EXCEL “controversy” (for me, on Twitter) is watching people without full understanding of “how a trial happens” sling the word “misconduct” around & call for NEJM to retract the paper because...there were changes to the protocol
7
34
138
@ADAlthousePhD
Andrew Althouse
5 years
Differences between men and women, volume 9372: there are currently 12 bottles of soap / shampoo / conditioner in our shower. One of these belongs to me. The remaining 11 belong to my wife.
18
10
114
@ADAlthousePhD
Andrew Althouse
4 years
Harms from uninformed reviewer comments: Today, my co-authors received a comment on our paper that questioned our sample size calculation because “higher power increases the chance for a Type II error” (not a typo: they said this in two different places in their review).
9
13
128
@ADAlthousePhD
Andrew Althouse
5 years
That time when a female medical student and a kind male mentor from a country with a severe gender bias problen decided to write a paper that they hoped would *combat* negative gender stereotypes in medicine, and twitter ate them alive for it.
7
21
126
@ADAlthousePhD
Andrew Althouse
4 years
Also anyone that suggests Trending Towards Significance will be blocked and reported
7
2
130
@ADAlthousePhD
Andrew Althouse
5 years
@DrMuzz57 @EndChildCrisis @ZackBergerMDPhD A few journals ( @JClinEpi , @AnnalsATS ) have adopted a very reasonable “we’ll review your first submission in any reasonable format, then worry about meeting final formatting requirements on the second round” which saves wasted time of reformatting papers headed for desk rejection
3
9
123
@ADAlthousePhD
Andrew Althouse
5 years
Thing that happened today, in 2019:
Tweet media one
16
7
124
@ADAlthousePhD
Andrew Althouse
5 years
Teaching highly educated and brilliant physicians how to use page breaks instead of hitting Enter 20 times to start a new page in a Word document.
@prof_nch
Nathan C. Hall
5 years
The longer I’ve stayed in academia, the more I’m convinced we all have an academic superpower. If you had to bet your career on it, what would yours be?
106
31
245
5
2
125
@ADAlthousePhD
Andrew Althouse
4 years
I'm probably about the 1,723rd person toc complain about this, but what is the point of Editorial Manager if you still have to create a new account every time you're a co-author on a paper for another journal?
9
4
128
@ADAlthousePhD
Andrew Althouse
2 years
Some musing thoughts on @rlmcelreath 's wonderful Statistical Rethinking.
3
15
134
@ADAlthousePhD
Andrew Althouse
4 years
Today in bad Reviewer Comments - we bring you the story of Reviewer Two stating that you cannot use a generalized linear model to analyze a binary outcome variable.
14
3
119
@ADAlthousePhD
Andrew Althouse
4 years
Hey @rwyeh , would you like to explain immortal time bias again?
@DrEricDing
Eric Feigl-Ding
4 years
⚠️EXCITING BLOOD THINNER study: “For patients on ventilators, the difference was more sig. About 63% of patients who did not receive the medications died compared with 29% who received [blood thinners]. Not a trial, but good cohort study... 🧵 #covid19
14
157
318
6
36
114
@ADAlthousePhD
Andrew Althouse
3 years
To people who are questioning the vaccine’s “true” efficacy because they note that people are wearing masks, distancing & say they don’t know if the low incidence of COVID in vaccine arm was due to vaccine or those measures...um, what do you think the control group is for?
4
4
119
@ADAlthousePhD
Andrew Althouse
5 years
Anyone: What’s your degree in? Me: Statistics. Most People: oh, I HATED that class in undergrad.
17
8
112
@ADAlthousePhD
Andrew Althouse
2 years
Update: it happened.
Tweet media one
@statsepi
Darren Dahly - on Bluesky and Substack
2 years
Meeting @ADAlthousePhD in real life next week. I hope he'll take a selfie with me!
8
0
74
11
2
123
@ADAlthousePhD
Andrew Althouse
5 years
The more that I think about it, the more I feel like simulations for power / sample size calcs are the way to go. Maybe it’s because I’m not a good enough math-stat person to power my way through more complex designs, but it just feels more natural. Anyone else feel the same?
17
8
114
@ADAlthousePhD
Andrew Althouse
6 years
"Reviewing scientific manuscripts: A comprehensive guide for peer reviewers" - applause for this effort from Katie Nason to provide some guidance. Not all researchers have been adequately trained to do this...
5
42
119
@ADAlthousePhD
Andrew Althouse
3 years
Reading the ASA discussion board every once in a while is a good reminder that anyone who thinks the solution to fixing medical research is "just make sure statisticians review every paper" has probably not met enough statisticians.
4
8
104
@ADAlthousePhD
Andrew Althouse
2 years
there's a special circle in hell reserved for people that send Doodle invites asking for people's availability in every 30-minute window from 8AM-7PM, all 5 days of the working week, for 2 straight months.
5
6
119
@ADAlthousePhD
Andrew Althouse
4 years
Here's a mushy thought that's been rolling around my head over the last few days as the reality of #COVID19 starts to sink in to more people: In the coming months, *everyone* is gonna have to give *everyone else* a little extra slack.
3
28
113
@ADAlthousePhD
Andrew Althouse
11 months
@f2harrell @arthur_alb1 @TheSGEM @GidMK @dnunan79 @EpiEllie @f_g_zampieri I feel like one of the hardest things to get people's mind around when reading any sort of power and sample size description is that the effect size used in the power calc is not (or should not be) what you think the effect **is** but rather the smallest effect of interest.
5
21
119
@ADAlthousePhD
Andrew Althouse
3 years
If I had a nickel for every time a reviewer says we have to redo the analysis because the data aren’t normally distributed, I’d have a whole bunch of nickels.
8
3
104
@ADAlthousePhD
Andrew Althouse
5 years
As many folks have explained, calculating post-hoc power using the observed effect size is just a transformed version of the p-value. OF COURSE STUDIES THAT FOUND NO SIGNIFICANT DIFFERENCE SEEM TO HAVE LOW POWER when you use the "observed" effect size to calculate power.
5
21
108
@ADAlthousePhD
Andrew Althouse
4 years
I’m pretty sure “we just used p=0.06 instead of p=0.05 but still did NHST” wasn’t what the “Retire Significance” authors had in mind...
@StuartJRitchie
Stuart Ritchie 🇺🇦
4 years
Amazing to see "rise up against statistical significance" backfiring (or, to be fair, being misunderstood) so badly. And it's just a paper about the coronavirus, so it's not like it MATTERS or anything...
Tweet media one
27
69
376
5
18
104